Pavel M. Vassiliev

Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents

Victor V. Fedotov, Ilya I. Butorin, Oleg S. Eltsov et al. · European Journal of Medicinal Chemistry · 2019 · 33 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +5

Synthesis and Evaluation of Novel [1,2,4]Triazolo[5,1‐<i>c</i>][1,2,4]‐triazines and Pyrazolo[5,1‐<i>c</i>][1,2,4]triazines as Potential Antidiabetic Agents

Anastasiya M. Bliznik, Valery N. Charushin, Pavel M. Vassiliev et al. · Archiv der Pharmazie · 2017 · 32 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus

Mikhail S. Dzyurkevich, Denis A. Babkov, Nikita V. Shtyrlin et al. · Scientific Reports · 2017 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Intraocular pressure lowering effect and structure-activity relationship of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds in ocular normotensive rats: Insight on possible link with hypotensive activity

Adrian Julian Marcus, Igor Iezhitsa, Renu Agarwal et al. · European Journal of Pharmaceutical Sciences · 2017 · 13 citations

Medicine, Ophthalmology, Pharmacology +10

Intraocular pressure-lowering effects of imidazo[1,2-a]- and pyrimido[1,2-a]benzimidazole compounds in rats with dexamethasone-induced ocular hypertension

Adrian Julian Marcus, Igor Iezhitsa, Renu Agarwal et al. · European Journal of Pharmacology · 2019 · 13 citations · Full text

Medicine, Ophthalmology, Pharmacology +8